Nemaura Medical (NMRD) Financials

$0.00

$-0.03 (-99.69%)

As on 24-Sep-2026 16:00EDT

Market cap

$0 Mln

Revenue (TTM)

$-2 Mln

P/E Ratio

--

P/B Ratio

122.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Operating Revenue	-1.55	0.08	0.50	--	--	--
Cost of Revenue	4.59	1.55	0.34	0.10	--	--
Gross Profit	-6.14	-1.48	0.16	-0.10	--	--
Operating Expenses	8.96	8.12	7.73	4.59	4.78	4.48
Operating Profit (EBIT)	-8.73	-9.60	-7.57	-4.59	-4.78	-4.48
Other Income	--	--	--	--	0.00	0.02
Profit before Tax	-10.65	-14.14	-14.24	-6.59	-4.77	-4.45
Provision for Tax	-1.60	10.96	-0.35	-0.34	-0.61	0.02
Profit after Tax (Net Income)	-10.65	-14.14	-13.89	-6.26	-4.16	-4.45
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-4.68	-14.14	-13.89	-6.26	-4.16	-4.45

Liabilities ($ Mln)	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Shareholder's Funds	-17.83	-11.81	0.47	8.36	-1.31	2.23
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	4.11	1.05	20.46	1.15	1.24
Current Liabilities	23.00	22.27	20.58	6.42	1.39	1.30
Total Liabilities	28.16	14.56	22.10	35.24	1.22	4.76

Assets ($ Mln)	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Non-Current Assets	0.80	1.03	2.01	1.26	0.38	0.25
Current Assets	4.37	13.54	20.09	33.99	0.84	4.52
Total Assets	28.16	14.56	22.10	35.24	1.22	4.76
Total Debt*	19.64	20.03	19.19	24.92	0.08	--
Net Current Assets	-18.62	-8.73	-0.49	27.57	-0.54	3.22

Cashflow ($ Mln)	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Cash From Operating Activities	--	-8.45	-6.50	-6.00	-3.45	-3.56
Cash Flow from Investing Activities	--	-0.54	-0.96	-0.84	-0.21	4.40
Cash from Financing Activities	--	2.08	-6.37	37.99	0.10	2.05
Net Cash Inflow / Outflow	--	--	--	31.15	-3.56	2.89

Financials Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Adjusted EPS ($)	-0.37	-0.49	-0.60	-0.27	-0.20	-0.21
Cash EPS ($)	--	-0.47	-0.59	-0.27	-0.20	-0.21
Adjusted Book Value ($)	--	--	0.02	0.36	--	0.11
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.29	-0.28	-0.26	-0.17	-0.17
Free Cash Flow per Share ($)	--	-0.31	-0.32	-0.30	-0.18	-0.18

Profitability Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
ROCE (%)	--	-101.50	-52.47	-39.06	-834.94	-140.51
ROE (%)	--	249.27	-314.74	-177.67	-910.37	-140.51
ROA (%)	-39.20	-77.15	-48.43	-34.33	-139.05	-80.82
EBIT Margin (%)	377.70	-10,034.83	-1,502.35	--	--	--
Net Margin (%)	685.64	-18,358.00	-2,755.83	--	-105,965.26	-18,609.93
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Revenue Growth (%)	-490.98	-0.85	--	--	--	--
EBIT Growth (%)	27.46	-2.12	-65.05	4.01	-6.74	-134.51
Net Profit Growth (%)	42.55	-1.85	-121.88	-50.44	6.57	-144.60
EPS Growth (%)	52.56	0.18	-1.18	-0.37	0.07	-0.25
Book Value Growth (%)	-50.81	--	--	--	--	--

Valuation Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Price / Earnings	--	-1.83	-7.34	-27.98	-29.41	-4.81
Price / Book Value	122.56	-2.19	218.59	20.95	-93.19	9.61
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-6.63	-4.91	-14.08	-37.47	-25.90	-3.98
Close Price ($)	0.22	0.90	4.37	7.64	5.86	10.30
High Price ($)	3.43	4.50	17.40	16.50	14.80	50.00
Low Price ($)	0.15	0.70	3.51	3.12	2.50	8.00
Market Cap ($ Cr)	0.00	--	--	--	--	--

Solvency Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Debt to Equity	--	-1.70	41.17	2.98	-0.06	--
Short term debt to equity ratio	-1.10	-1.43	41.17	0.69	-0.70	0.43
Current Ratio	0.19	0.61	0.98	5.29	0.61	3.48
Quick Ratio	0.03	0.53	0.90	5.16	0.40	3.45
Interest Coverage	-0.88	-1.21	-1.14	-2.28	-1,217.14	--

Operating Efficiency Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14
Debtors to sales (%)	-15.95	531.71	20.10	--	--	--
Asset Turnover	-0.06	0.00	0.02	--	--	--
Receivable days	--	1,211.14	69.08	--	--	--
Inventory Days	--	381.21	1,240.34	2,117.07	--	--
Payable days	--	54.43	206.87	1,019.13	--	--
Cash Conversion Cycle	--	1,537.93	1,102.56	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.